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Background: Some drugs of abuse down regulate the expression of cystine/glutamate
(xCT) antiporter in the nucleus accumbens (Acb) after extinction or withdrawal. The
altered level of xCT exchanger in Acb, a structure involved in ethanol reinforcement,
may contribute to the pathological glutamatergic signaling, linked to addiction. We
hypothesized that the expression of xCT may be changed in Acb and whole brain also
in non-dependent (occasional drinkers), ethanol-dependent rats, as well as, during ethanol
withdrawal.
Methods: Wistar rats were made ethanol-dependent by chronic exposure to an alcoholic
milk beverage (from 2.4 to 7.2% v/v ethanol). Ethanol non-dependent rats were exposed to
a similar, but non-alcoholic liquid diet and self-administered ethanol (10%) twice a week.
Withdrawal in ethanol-dependent rats was studied at 12 h after the last ethanol-enriched
diet exposure. Immediately after the measurement of somatic signs of withdrawal,
Western blot analysis with a polyclonal antibody against xCT was carried out in a naïve
control group, non-dependent and ethanol-dependent rats as well as withdrawal rats, in
order to study the level of xCT expression in Acb and whole brain.
Results: Non-dependent rats self-administered an average dose of 1.21 ± 0.02 g/kg per
session (30min). Daily ethanol consumption during chronic exposure to the alcoholic
beverage ranged from 6.30 ± 0.16 to 13.99 ± 0.66 g/kg. Ethanol dependent rats
after suspension of the ethanol-enriched diet have shown significant somatic signs of
withdrawal. Western blotting analysis of Acb lysates revealed that xCT was over expressed
in ethanol-dependent rats whereas in whole brain preparations xCT was over expressed
in both non-dependent and ethanol-dependent rats compared to control group. On the
contrary, xCT expression during withdrawal was down regulated in Acb and restored to
control level in whole brain preparations.
Conclusions: The changes of xCT expression in both Acb and whole brain following
ethanol dependence and withdrawal indicate that xCT might represent a novel therapeutic
target for the treatment of ethanol addiction.
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INTRODUCTION
The development of ethanol dependence is posited to involve
numerous changes in brain neurotransmission that lead to char-
acteristic physiological signs upon abstinence from ethanol.
Increased glutamatergic neurotransmission appears to medi-
ate the reinforcing properties of ethanol and changes are
considered responsible of affecting many aspects of neuroplas-
ticity associated with ethanol dependence (De Witte et al., 2005;
Knackstedt and Kalivas, 2009; Bridges et al., 2012; Griffin Iii
et al., 2014; Lum et al., 2014). The increase of extracellular glu-
tamate caused by ethanol in many brain areas, could be related
to the glutamate/cysteine exchanger presence in a wide variety
of neuronal cells (Lewerenz et al., 2012). It is well known that
the glutamate/cystine antiporter transports cystine into neuronal
cells in exchange of glutamate at a ratio of 1:1. It is composed
of a catalytic light chain subunit, xCT (also known as system
xc- or Slc7a11), which mediates the ion co-transport, and a reg-
ulatory heavy chain subunit (4F2), linked by a disulfide bridge
(Lewerenz et al., 2012). Internalized cystine is reduced into cys-
teine, the rate-limiting precursor of glutathione (GSH), while the
externalized glutamate can contribute to either excitatory signal-
ing or excitotoxicity (Seib et al., 2011). Particularly, drugs of abuse
such as cocaine (Knackstedt et al., 2010) and nicotine (Knackstedt
et al., 2009) produce a down-regulation of xCT antiporter, stud-
ied byWestern blot analysis in different brain areas, either 3 weeks
after cocaine extinction (Knackstedt et al., 2010) or 12 h after
the last nicotine treatment (i.e., during withdrawal) (Knackstedt
et al., 2009). This reduction in xCT system occurs, among other
brain areas, in the Acb and may contribute to the pathological
glutamate signaling linked to addiction (Bridges et al., 2012).
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Recently, Pochareddy and Edenberg (2012) demonstrated that
long-term ethanol exposure in vitro results in altered expression
of roughly thousand genes in human hepatoma cells (HepG2)
among which the Slc7a11 gene, has been shown to be expressed at
higher levels (1.54-fold), whereas other authors have shown that
ethanol, dose-dependently, increases the xCT exchanger expres-
sion in mouse hepatic stellate cells (Lin et al., 2013). Notably,
the main function of the xCT antiporter is to maintain the
intracellular level of glutathione and protect cells from oxida-
tive damage (Bannai, 1986; Pochareddy and Edenberg, 2012).
Thus, up-regulation of xCT expression might be a compensatory
mechanism in response to ethanol-induced oxidative stress. At
present, little information is available concerning the role of xCT
antiporter in the brain of both ethanol non-dependent (occa-
sional drinkers) and ethanol-dependent rats as well as during
withdrawal in ethanol-dependent rats. For this purpose, two
groups were made dependent on ethanol by chronic exposure
to an ethanol-containing liquid diet, prepared from cow’s milk
with some additions. Validation of the ethanol-containing liq-
uid diet’s ability to induce dependence (Uzbay and Kayaalp,
1995) was confirmed by the appearance of the ethanol with-
drawal syndrome after ethanol suspension (Macey et al., 1996).
Ethanol non-dependent rats (occasional drinkers) were exposed
to a similar, but non-alcoholic liquid diet and were allowed to
self-administer ethanol twice a week.
Western blot experiments were performed using both Acb and
whole brain homogenates to determine if xCT expression was
changed by the different experimental conditions.
MATERIALS AND METHODS
The study was carried out in accordance with the current Italian
legislation [D.L. 116, 1992], which allows experimentation on
laboratory animals only after submission and approval of a
research project to the Independent Committee of Bioethics of
the University for Animal Testing (Sassari, Italy) and to the
Ministry of Health (Rome, Italy), and in strict accordance with
the European Council directives on the matter [n. 2007/526/CE].
All possible efforts were made to minimize animal pain and
discomfort and to reduce the number of experimental subjects.
DRUGS AND CHEMICALS
Ethanol solutions (v/v) obtained by dilution of ethanol (95%; U.S.
Pharmacopeia National Formulary, 1995) with tap water were
freshly prepared before every session of self-administration. xCT
polyclonal antibody was from Abnova (Taipei, Taiwan). β-tubulin
antibody was purchased from Sigma-Aldrich (St. Louis, MO,
USA). Both anti-mouse and anti-rabbit IgG-coupled horseradish
peroxidase antibodies as well as enhanced chemiluminescence
(ECL) reagents were from Cell Signaling Technology (USA). All
other reagents were of the highest purity grade commercially
available.
ANIMALS
Male Wistar rats (n = 58) (Harlan, Udine, Italy), weighing
175–225 g at the beginning of the experiment, were housed in
pairs in Plexiglas cages. The colony room was maintained under
controlled environmental conditions (temperature 22 ± 2◦C;
humidity 60–65%) under a 12-h light/dark cycle (light on at
8:00 h; off at 20:00 h).
Four groups of rats were utilized for this study:
1. Ethanol non-dependent rats allowed to self-administer
ethanol twice a week (Monday and Thursday; n = 8). These
rats were fed the non-alcoholic liquid diet.
2. Ethanol dependent rats (n = 27). These rats were fed the
alcoholic liquid diet.
3. Ethanol dependent withdrawn: rats (n = 17) after suspension
of the ethanol-enriched diet.
4. Control rats that was used only for xCTmeasurements, fed the
non-alcoholic liquid diet (n = 6).
Both groups of rats, non-dependent and dependent have, in the
home cage, a bottle of milk (liquid diet) with (dependent) or
without ethanol (non-dependent). Non-dependent rats (occa-
sional drinkers) drank for 30min (twice a week) the “desired”
amount of ethanol. Instead, the dependence was induced by
“forced” ethanol liquid diet (method of Uzbay and Kayaalp,
1995).
LIQUID DIET COMPOSITION
The rats were given a modified liquid diet with (ethanol depen-
dent) or without (control and ethanol non-dependent) ethanol
ad libitum. No extra chow or water was supplied. The composi-
tion of the modified liquid diet with ethanol is:
fresh whole cow milk, 910–970ml (CoaPla, Italy)/l;
ethanol 25–75ml/l;
vitamin A 5000 IU/l
sucrose 17 g/l.
This mixture (with or without ethanol), freshly prepared daily,
according to the method of Uzbay and Kayaalp (1995), supplies
1000.7 kcal/l. Briefly, the liquid diet without ethanol contains
17 g of sucrose instead, the liquid died with ethanol, at the time
when ethanol concentration is increased, sucrose was reduced to
maintain isocaloricity of the diet. The beverage (with or without
ethanol) was presented at the same time of the day (09:30 h AM)
for 24 h.
ETHANOL ADMINISTRATION IN NON-DEPENDENT RATS (OCCASIONAL
DRINKERS)
Training was conducted in modular operant chambers, located
in ventilated soundproof environmental cubicles (Med Associates
Inc. USA). Each chamber was equipped with a non-retractable
drinking cup (capacity 0.50ml) and two nose-poke holes located
3 cm to the left and right of the cup. A white light placed above
the active hole and an orange light placed above the inactive hole
were used as environmental stimuli. Only the active nose-poke
hole set off the dipper-delivering solution (0.1ml) into the drink-
ing cup in 3.05-second period. Explorations at both the active and
inactive nose-poke holes were recorded. In particular, recording at
the inactive hole served to control for specificity of the response
in the operant chamber. The availability of liquid was signaled
by a house light placed on the wall in front of the drinking cup
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that would light up for the duration of liquid delivery. Following
each delivery, there was a 2-second time-out period during which
responses had no consequences and the white light placed above
the active hole went off. An infrared head detector was located
in the reservoir and recorded all signals during the entire ses-
sion. The chambers were interfaced to a computer equipped with
software that ran the programmed sessions and recorded the
data. For operant ethanol (5–10% v/v) self-administration, rats
were trained to nose-poke under a fixed-ratio 1 (FR1) sched-
ule of reinforcement, in which each response resulted in 0.1ml
of solution delivery. From day 1 to day 6, rats were permit-
ted to nose-poke explore for 5% ethanol solution. Starting on
day 7, the ethanol percentage was gradually increased, with daily
increases of 1% up to the final concentration of 10%. Following
the acquisition, after a stable baseline of responding was reached,
operant self-administration of ethanol was then increased to a
FR2 schedule until the self-administration behavior was stable
and subsequently, the schedule requirement was increased to a
FR3 (Peana et al., 2013). After this period (approximately 30 days
from acquisition training) the non-dependent rats (occasional
drinkers) were allowed to self-administer ethanol twice a week
(Monday and Thursday at 9.00 h).
ETHANOL ADMINISTRATION IN DEPENDENT RATS
At the beginning of the study, the rats were given the liquid diet
without ethanol for 7 days. Then, liquid diet, for inducing ethanol
dependence, was gradually enriched with 2.4% (3 days), 4.8%
(4 days) and 7.2% (14 days) ethanol. This diet composition and
regimen has been reported to result in a significant correlation
between ethanol-containing liquid diet consumption and blood
ethanol level after 21 days of treatment, as reported by Kayir and
Uzbay (2008). Rat’s body weight (g), liquid intake (ml/kg) as well
as ethanol intake (g/kg) were recorded daily.
OBSERVATION OF SOMATIC SIGNS OF WITHDRAWAL
Withdrawal in ethanol-dependent rats was studied at 12 h after
the last ethanol-enriched diet exposure. Withdrawal behavioral
signs were determined exactly at 12 h after ethanol suspension.
Each subject was placed under white light conditions in Plexiglas
observation chambers (25 × 20 × 25 cm) and observed for 5min
by an observer blind to the subject’s treatments. The following
somatic signs of withdrawal were recorded: body tremors (BT),
tail rigidity (TR), vocalization (VOC) and ventro-medial limb
retraction (VmLR). We used a rating scale adapted from Macey
et al. (1996) as follows: 0 = no sign, 1 = moderate, 2 = severe.
To measure anxiety-like responses upon ethanol withdrawal,
the elevated plus maze (EPM) test was used. The test was per-
formed immediately, after 12 h after ethanol suspension. The
apparatus consisted of 2 gray Plexiglas open arms and 2 black
enclosed arms (40-cm high walls), with similarly shaped arms
opposite to each other. The 5-min test procedure began when the
animal was placed in the center of the maze, facing an open arm.
The time (min) spent in open arms and the number of open arm
entries were scored and used as measure of anxiety-like behavior
(Cruz et al., 1994).
All behavioral testing for ethanol non-dependent and for
dependent rats were determined at the same time corresponding
exactly at 12 h after ethanol suspension in abstinent rats. All
experiments were carried out during the light period in a room
with a soft light.
CYSTINE/GLUTAMATE ANTIPORTER EXPRESSION
Immediately after the behavioral observations, rats were intra-
peritoneally injected with 1.3 g/kg of ethylic urethane (Sigma-
Aldrich, Milan, Italy). Under deep anesthesia, rats were sacrificed
and brains removed and immediately frozen at −80◦C (4 h)
before being sectioned. Brains were rapidly dissected into coronal
sections on an ice-cooled metal plate using a scalpel. The brain
regions were identified according to the rat brain atlas (Paxinos
and Watson, 1998) and from these slices two sections (approxi-
mately 2mm thick), containing Acb, were isolated and identified
by visual inspection and direct comparison with the images of
the rat brain atlas in stereotaxic coordinates corresponding to
AP +1.7 to +1.9mm from bregma (Paxinos and Watson, 1998).
The bilateral brain sites containing Acb (shell an core; control
group: n = 3; ethanol non-dependent: n = 5; ethanol dependent:
n = 7; withdrawal in ethanol dependent: n = 7) and whole brain
sections (control group: n = 3; ethanol non-dependent: n = 3;
ethanol dependent: n = 3; withdrawal in ethanol dependent: n =
3) were suspended in saline and subsequently homogenized as
described below.
BRAIN AND NUCLEUS ACCUMBENS HOMOGENATES PREPARATION
Acb-containing slice portions or whole brains including Acb
were weighted and homogenized in 1ml and 4ml, respec-
tively, of ice-cold lysis buffer (20mM Tris–HCl, pH 7.5, con-
taining 150mM NaCl, 1mM EDTA, 1mM EGTA, 1% Triton
X-100, 1mM phenylmethylsulfonylfluoride (PMSF), 1mM
β-glycerophosphate, 2.5mM sodium pyrophosphate, 1mM
Na3VO4 and 1μg/ml leupeptin). Homogenization was carried
out with a Dounce homogenizer using 20 strokes of the loosely fit-
ting pestle. The lysates were sonicated with an ultrasonic homog-
enizer (BioLogics, USA) for 20 s on ice at 20% amplitude, and
centrifuged at 12,000 × g for 15min at 4◦C. The protein con-
tent of supernatants was measured according to Bradford (1976),
using bovine serum albumin (BSA) as a standard. Lysates were
used immediately for sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and Western blot analysis or stored
at −20◦C until future analysis.
WESTERN BLOT
Aliquots of protein lysates (80μg) were separated on 12% SDS
gel (Laemmli, 1970) and transferred to nitrocellulose membranes
at 250mA (constant current) for 1 h according to Towbin et al.
(1979). After transfer the blot was saturated in TBS (20mM Tris-
HCl, pH 7.0, 150mMNaCl), containing 5% non-fat milk powder
(MP) and 0.05% Tween 20 for 1 h at room temperature (RT). The
immunoreaction was carried out in TBS, 5% MP, 0.05% Tween
20, containing the Slc7a11 (xCT) polyclonal antibody diluted
1:1000 overnight at 4◦C. After being washed three times with TBS,
5% MP, 0.05% Tween 20 (5min each), the blot was incubated
with goat anti-rabbit Ig-coupled horseradish peroxidase diluted
1:2000 in TBS, 5% MP, 0.05% Tween 20 for 1 h at RT. The nitro-
cellulose sheet was rinsed three times in TBS, 5% MP, 0.05%
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Tween 20 (5min each) and once in water (10min), before devel-
oping the reaction by ECL. After extensive washing with TBS, the
bzlot was reprobed for the presence of β-tubulin with a mono-
clonal antibody diluted 1:1000 in TBS, 5% MP, 0.05% Tween 20
for 1 h at RT. Results were recorded on X-ray film (Kodak, USA)
and analyzed by densitometric scanning using the ImageJ 1.47v
open source public domain software developed at the National
Institutes of Health, USA (http://imagej.nih.gov/ij/).
STATISTICAL ANALYSIS
All values are expressed as mean (± s.e.m.). Ethanol intake val-
ues (in dependent rats) were analyzed by one-way ANOVA. Rat
body weights were analyzed by two-way ANOVA (repeated mea-
sure). The 4 different withdrawal signs (VOC, TR, BT and VmLR)
were assessed by individual comparison among individual means
using the non-parametric Mann-Whitney U-test. Numbers of
open arm entries were analyzed by two-way ANOVA. Time spent
in open arms were analyzed by one-way ANOVA. In the presence
of overall significant main effects and interactions (p-values <
0.05), the Least Significant Differences (LSD) post-hoc test was
performed.
Following densitometric analysis of the Western blot autora-
diograms, data were expressed as arbitrary units (A.U.) of 3 dif-
ferent experiments ± s.e.m. and analyzed by unpaired Student’s t
test, assuming a p < 0.05 as statistically significant. A power anal-
ysis for t-test with the free software G∗Power 3.1 (http://www.
gpower.hhu.de/) was also carried out. The results of this analysis
gave a power (1-β err prob = 0.95) with a sample size of 3 and an
α level of 0.05. Being the power higher than 0.80 (Faul et al., 2007)
there was no need to increase the sample size.
RESULTS
ETHANOL NON-DEPENDENT (OCCASIONAL DRINKERS) AND ETHANOL
DEPENDENT RATS
Non-dependent rats, allowed to self-administer ethanol (10%)
twice a week, self-administered an average dose of 1.21 ±
0.02 g/kg per session (30min).
Daily ethanol consumption during chronic exposure to the
alcoholic beverage (from 2.4 to 7.2% v/v ethanol) ranged from
6.30 ± 0.16 to 13.99 ± 0.66 g/kg. One-way ANOVA revealed a
significant increase in ethanol consumption along the exposure
time [F(1, 52) = 127.18, p < 0.0001].
Average body weights in ethanol-dependent rats showed a pro-
gressive decrease from the beginning to the end of the study
compared with ethanol non-dependent groups. However, sig-
nificant main effects of group [F(1, 33) = 2.57, p = 0.012], time
[F(1, 33) = 42.35, p < 0.0001] and a significant group x time
interaction [F(1, 33) = 62.21, p < 0.0001] revealed that the alco-
holic beverage was responsible of a significant loss of body weight
in ethanol-dependent rats.
SOMATIC SIGNS OF WITHDRAWAL IN DEPENDENT RATS
Figure 1A shows withdrawal signs, 12 h after suspension of the
ethanol-enriched diet. Mann-Whitney U-tests, used to com-
pare behavioral changes (scores) among ethanol withdrawal with
respect to both ethanol non-dependent and ethanol-dependent
groups, revealed a significant effect of withdrawal (p < 0.001).
In particular, as shown in Figure 1A, analysis of individual with-
drawal signs revealed a significant overall effect of ethanol with-
drawal on VOC (p < 0.05), TL (p < 0.05), BT (p < 0.05) and in
VmLR (p < 0.05) with respect to both ethanol non-dependent
and ethanol-dependent groups. No changes were observed
between ethanol non-dependent and ethanol-dependent groups.
Figures 1B,C shows the results of the anxiety-like behavior
test following chronic exposure to ethanol on EPM test as deter-
mined by assessing the number of entries into open arms with
respect to the total entries and average time spent into open
arms. Repeated measures two way ANOVA revealed a significant
main effect of treatment [F(2, 32) = 4.78, p = 0.015], of open-
closed/session entries [F(1, 32) = 232.56, p < 0.0001] but not a
significant treatment x open-closed/session entries interaction
[F(2, 32) = 2.62, p = 0.08] indicating a significant difference for
entries into open arms between withdrawal vs. ethanol non-
dependent group (p < 0.0001) and ethanol dependent group
and a significant difference for entries into total arms between
withdrawal vs. ethanol non-dependent group (p < 0.0001). In
addition, there was a non-significant difference between with-
drawal and ethanol-dependent group both into open arms and
into total arms entries (Figure 1B). Moreover, one way ANOVA
[F(2, 32) = 11.86, p = 0.00014] indicated a significant difference
for time spent into open arms between ethanol non-dependent
vs. ethanol-dependent (p = 0.0015) and between ethanol non-
dependent vs. withdrawal groups (p < 0.0001) (Figure 1C).
CYSTINE/GLUTAMATE ANTIPORTER EXPRESSION
The expression of xCT in Acb and whole brain homogenates
was investigated by Western blot analysis. The antibody recog-
nizes a band of about 40 kDa, which corresponds to the more
active xCT isoform (Sato et al., 1999). Western blot experiments
in lysates obtained from Acb (Figure 2A), revealed the presence
of xCT in control group and a similar level of xCT expression in
non-dependent rats. In ethanol-dependent rats there was a signif-
icant increase of xCT expression, compared to controls (p < 0.05)
and non-dependent rats (p < 0.05). Following 12 h withdrawal in
dependent rats, the level of xCT expression with respect to control
(p < 0.05), non-dependent (p < 0.05) and ethanol-dependent
(p < 0.05) samples, was significantly down regulated. The results
of 3 experiments, expressed as A.U., are shown in Figure 2B.
Western blot experiments in lysates obtained fromwhole brain
(Figure 3A), revealed the presence of xCT in control group.
Moreover, xCT expression was significantly higher in ethanol
non-dependent compared to control group (p < 0.05). The level
of protein was even more increased in brain of rats dependent
from ethanol, and this increase was significantly different from
control group (p < 0.05) and ethanol non-dependent (p < 0.05).
Following withdrawal, the level of xCT expression was restored to
the level of control group (Figure 3B).
DISCUSSION
It is well known that many drugs of abuse can change the expres-
sion level of xCT in animal models of addiction and in humans
(Knackstedt et al., 2009, 2010). The aim of the present study has
been, therefore, to evaluate whether the expression of xCT may
be modified by ethanol in the Acb and whole brain of ethanol
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FIGURE 1 | Somatic signs of ethanol withdrawal assessed 12h after the
lastethanol intake independents rats.Eachwithdrawal sign (VOC,TR,BTand
VmLR) was assigned a score from 0 to 2. Values represent the mean (± s.e.m.)
of 8–17 subjects per group. Ethanol non-dependent and ethanol dependent
rats did not show withdrawal signs. Statistical difference with respect to the
ethanol non-dependent (score: 0) and ethanol dependent (score: 0) groups (not
shown in figure) was expressed as ∗(A). Open arm entries and total arm entries
were shown in (B); time spent in open arms is shown in (C). Values represent
the mean (± s.e.m.) of 8–17 subjects per group. Statistical difference with
respect to the ethanol non-dependent group was expressed as ∗.
non-dependent rats (occasional drinkers), ethanol-dependent
rats, as well as, during ethanol withdrawal.
Strong evidence indicates that the disruption of glutamate
homeostasis is associated with addictive disorders (Kalivas et al.,
2009). The alterations in glutamate concentrations observed fol-
lowing prolonged exposure to drugs of abuse are associated
with changes in the function and activity of several key compo-
nents of the homeostatic control mechanism, including the xCT
exchanger and the glial glutamate transporter (GLT-1). The glu-
tamatergic system in the prefrontal cortex has been suggested to
be involved in drug reinforcement (Goldstein and Volkow, 2002),
and the role of glutamate projections from prefrontal cortex to the
Acb and the VTA has been elucidated in clinical studies and in ani-
mal models of drug abuse (Goldstein and Volkow, 2002; Kalivas
et al., 2009).
In the Acb core, about 60% of the basal level of extracellular
glutamate is derived from the activity of the xCT (Baker et al.,
2002). Many drugs of abuse can modify the glutamate concentra-
tion in the Acb, by interfering with the xCT activity or expression.
The Acb is therefore regarded as a specialized brain area involved
in the neurobiology of addiction (Reissner and Kalivas, 2010)
and the xCT antiporter may be a target for the design of drugs
to be used for the prevention of drug abuse (Bridges et al.,
2012).
We hypothesized that similarly to the dependence mechanisms
from other drugs of abuse, ethanol dependence may also change
the expression of xCT. In our experiments, the xCT expression
studied in the Acb homogenates from ethanol-dependent animals
was strongly increased with respect to control group and ethanol
non-dependent group (occasional drinkers). On the other hand,
the xCT expression was strongly decreased in Acb homogenates of
ethanol-dependent animals after 12 h withdrawal. These changes
in xCT expression could be responsible for alterations in gluta-
mate levels in the Acb that may occur in response to chronic
ethanol exposure and that may contribute to the pathological
glutamate signaling linked to withdrawal-induced behavior. The
profound down-regulation in the expression of xCT in the Acb,
following 12 h of withdrawal in dependents rats could be also
linked to the recidivism for ethanol abuse after a period of
abstinence (Knackstedt and Kalivas, 2009). The decrease of xCT
expression in the Acb isolated from ethanol withdrawal group
seems to be in line with other studies reporting similar results
with two different addictive drugs, cocaine (Baker et al., 2003;
Madayag et al., 2007; Kau et al., 2008; Knackstedt et al., 2010),
and nicotine (Knackstedt et al., 2009), after extinction or after
acute withdrawal of the drugs. It must be noted that, while
chronic cocaine (Baker et al., 2003) and nicotine (Knackstedt
et al., 2009), exposure may produce a decrease in basal extra-
cellular glutamate levels (with reduced xCT expression possibly
contributing to this effect), chronic ethanol exposure could result
in an increased extracellular glutamate concentrations due to the
xCT overexpression.
The balance between xCT and GLT-1 activities has a profound
effect on the regulation of extrasynaptic glutamate levels and on
the signaling through pre- and post-synaptic glutamate recep-
tors, thus affecting synaptic plasticity and circuit-level activity
(Kalivas et al., 2009). Besides the reduction of xCT expression,
both cocaine and nicotine also reduce the levels of GLT-1 in the
Acb, after extinction or after acute withdrawal of the drugs; more-
over, the expression level of both xCT and GLT-1 was restored
by the beta-lactam antibiotic ceftriaxone, known to induce the
GLT-1 in the same experimental models (Knackstedt et al., 2009,
2010).
Other studies have demonstrated that ceftriaxone induces the
up-regulation of the GLT-1 also in alcohol-preferring rats, and
a dose-dependent reduction of ethanol consumption (Sari et al.,
2011). Collectively, these data indicate that cocaine, nicotine, and
ethanol could change the extracellular glutamate concentration in
brain regions important for the development and/ormaintenance
of drug dependence via alteration of glutamate transporters. Our
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FIGURE 2 | (A) xCT expression in Acb isolated from rat brain submitted to
various treatments. The Acb homogenates were prepared as described in the
Materials andMethods Section and processed byWestern blot analysis using a
specific polyclonal antibody against xCT. Lane 1: Control. Lane 2: ethanol
non-dependent. Lane 3: ethanol-dependent. Lane 4: withdrawal. The bottom of
the figure shows the level of β-tubulin in the same samples, used as control
protein loading on the gel. The results showed are from one experiment out of
three separate experiments. (B) Densitometric analysis of results showed in
(A). The level of xCT was normalized relative to β-tubulin (xCT/β-tubulin ratio ×
10). Values represent themean± s.e.m. of three independent experiments and
are expressed as arbitrary units (A.U.). ∗p < 0.05 vs. control; ◦p < 0.05 vs.
ethanol non-dependent; #p < 0.05 vs. ethanol-dependent rats.
results suggest that ethanol dependence could increase the level
of extracellular glutamate in the Acb, while ethanol withdrawal
could decrease the amino acid concentration in the same brain
area. This conclusion is based only on the xCT expression pro-
file seen in the Acb and it is highly speculative, since we do
not know what happens to the GLT-1 expression or to extracel-
lular glutamate concentrations, which were not investigated in
this work. However, many studies have demonstrated that the
levels of extracellular glutamate are increased in central brain
reward regions following chronic ethanol exposure and with-
drawal (De Witte, 2004; Griffin Iii et al., 2014; Lum et al., 2014).
If an increase in glutamate transmission plays a role in ethanol
consumption associated with dependence, as these studies sug-
gest, then the functional consequence of an increase/reduction of
xCT exchanger in the Acb could be relevant in the development
and/or manifestation of ethanol dependence (Knackstedt et al.,
2009).
The results of Western blot analysis with whole brain
homogenates showed that non-dependent rats (self-administered
ethanol twice a week) have higher levels of xCT expression
than control group, and a further significant increase of xCT in
ethanol-dependent rats, in which xCT expression was reduced
to control values after 12 h withdrawal. These data suggest that
an intermittent (ethanol self-administration, twice a week), or a
long-term ethanol exposure (in the liquid diet), cause an increase
of the xCT in the whole brain. Interestingly, these results are
in agreement with data obtained from Lin et al. (2013), who
reported that ethanol treatment up-regulates xCT expression in
vitro (Lin et al., 2013).
The activity of xCT contributes to the maintenance of a cellu-
lar redox balance, sufficient to protect cells from oxidative damage
(Sato et al., 2005). Thus, the up-regulation of xCT expression
might be a compensatory mechanism in response to ethanol-
induced oxidative stress (Lin et al., 2013). Since the main function
of xCT in the CNS, as well as in other systems, is to control
the glutathione (GSH) synthesis, every condition that increases
the production of oxygen free radicals, could lead to the up-
regulation of xCT.
In many neurological conditions, such as inflamma-
tion/degenerative diseases (Pampliega et al., 2011), hypoxic
diseases (Jackman et al., 2010), epilepsy and brain tumors
(Lewerenz et al., 2014), the transcription of the Slc7a11 gene
is increased. In our opinion, the ethanol dependence can be
considered similar to these pathological states, where there is a
concomitant up-regulation of the xCT protein. It is noteworthy
that ethanol metabolism generates reactive oxygen species
and creates a state of oxidative stress in hepatocytes (Bailey
et al., 1999). In response to oxidative stress, the transcription
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FIGURE 3 | (A) xCT expression in rat brain homogenates. The brain
homogenates were prepared as described in the Materials and Methods
Section and processed by Western blot analysis using a specific polyclonal
antibody against xCT. Lane 1: Control brain. Lane 2: ethanol non-dependent.
Lane 3: ethanol-dependent. Lane 4: withdrawal. The bottom of the figure
shows the level of β-tubulin in the same samples, used as control protein
loading on the gel. The results showed are from a single experiment,
repeated at least three times. (B) Densitometric analysis of results showed in
(A). The level of xCT was normalized relative to β-tubulin (xCT/β-tubulin
ratio × 10). Values represent the mean ± s.e.m. of three independent
experiments and are expressed as arbitrary units (A.U.). ∗p < 0.05 vs. control;
#p < 0.05 vs. ethanol non-dependent ◦p < 0.05 vs. ethanol dependent rats.
factor nuclear factor-erythroid 2-related factor 2 regulates
expression of multiple genes involved in antioxidant defense
mechanisms (McMahon et al., 2001). Moreover, oxygen and
hydrogen peroxide are able to induce the xCT gene transcrip-
tion in many experimental models (Sato et al., 2005). The
increased expression of xCT caused by ethanol in the whole
brain might be a general protective neuronal mechanism from
oxidative stress, based on the increase of the GSH synthesis. In
addition, the increased production of GSH, due to the higher
activity of xCT, might also act as a link between antioxidant
properties and the extracellular concentration of glutamate.
As previously mentioned, the extracellular glutamate concen-
tration is regulated by the xCT exchanger present mainly on
glial cells, and by the high affinity Na+-dependent GLT-1,
present on both glial and neuronal cells (Baker et al., 2002).
Therefore, impaired function of these transporters can have
a profound effect on extracellular glutamate concentrations
and cause a dysregulation of glutamate homeostasis not only
in the Acb, but also in the whole brain (Reissner and Kalivas,
2010). Nonetheless, studies in experimental animal models
have shown that ethanol (Bailey et al., 1999; Dahchour et al.,
2005), cocaine (Dietrich et al., 2005), heroin (Pan et al., 2005),
and nicotine (Jain and Jaimes, 2013) increase reactive oxygen
species.
The changes in xCT expression in Acb and whole brain
induced by ethanol dependence seem to be tissue-specific, since
we did not observe a similar pattern in rat spleen, an organ
that shows a relatively high constitutive level of xCT expression
(Taguchi et al., 2007) (data not shown).
In summary, our results show that ethanol dependence up-
regulates the expression of xCT antiporter in the Acb, a structure
involved in ethanol reinforcement, while 12 h ethanol withdrawal
strongly reduces the expression of xCT. The down-regulation of
xCT correlates with the withdrawal symptoms observed in ani-
mals and suggests that treatment with drugs able to restore the
xCT level (i.e., N-acetylcysteine, ceftriaxone) could be useful for
the management of ethanol withdrawal symptoms. xCT is also
over-expressed in the whole brain homogenates from both non-
dependent and ethanol dependent rats and restored to control
level following ethanol withdrawal, probably as a consequence
of the brain oxidative stress induced by ethanol exposure and
by ethanol deprivation in withdrawal, respectively. Overall, these
findings indicate that xCT expression is altered in both the Acb
and the whole brain. xCT might therefore represent a novel
therapeutic target for the treatment of ethanol abuse.
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